Top 5 Life Sciences Stocks To Buy Right Now

With the Federal Reserve standing pat this week, the S&P 500 index has reached another all-time high.

Yet this bull market is proving to be even more fertile for investors in small-cap and micro-cap stocks. Both the iShares Russell Microcap Index and the Russell 2000 Small Cap Index are outperforming the S&P 500 by a solid margin over the past two years.

With no end in sight to the bull market, there's no reason to stop focusing on these small companies at this juncture. If the economy can manage to build a head of steam in 2014 and 2015, then these small stocks should see even deeper investor interest.

Here are three stocks that all trade below $5 and sport market values below $500 million -- and are poised for solid upside if this rally continues.

1. Lionbridge Technologies (Nasdaq: LIOX) I took note of heavy insider buying at this language translation services firm back in July, and though shares are up nearly 10% since then, the company's outlook has brightened markedly. 

On the second-quarter conference call, management delivered its most upbeat discussion of business trends in several years, noting that Lionbridge is seeing an expansion in its relationship with Microsoft (Nasdaq: MSFT), the return of several other large tech clients that had dropped off in the past few years, and a rising order book with manufacturing and life sciences clients. 

Hot Regional Bank Stocks To Own Right Now: Kirrin Resources Inc (KIRRF.PK)

Kirrin Resources Inc. (Kirrin) is a development-stage company. The Company's principal business is the acquisition, exploration and development of uranium and rare earth elements resources properties. Kirrin operates two REE properties, Grevet in Quebec and Bottom Brook in Newfoundland and one uranium project, Alexis River, in southeastern Labrador. It holds its property interests through its wholly owned Alberta subsidiary, Kirrin Exploration Inc. (KEI). It has an option agreement with Altius Resources Inc. to earn a minimum 60%, maximum 100% interest in the Alexis River uranium property, located in southeastern Labrador. It has an option agreement with Ucore Rare Metals Inc. to earn a minimum 50%, maximum 65% interest in the Lost Pond/Bottom Brookrare earth elements and uranium property, located in western Newfoundland. It has an option agreement with Michel Proulx to earn a 100% interest over four years in the Grevet rare earth elements property located in northwestern Quebec. Advisors' Opinion:

• [By The Gold Report]

  Tickers related to the original interview with Don Mosher include: Teck Resources (TCK) and Kirrin Resources (KIRRF.PK).

  DISCLOSURE:
  1) Streetwise Reports does not accept stock in exchange for its services or as sponsorship payment.
  2) Kevin Campbell: I was not paid by Streetwise Reports for participating in this interview. Comments and opinions expressed are my own comments and opinions and may not represent those of Haywood Securities. I had the opportunity to review the interview for accuracy as of the date of the interview and am responsible for the content of the interview.
  3) Interviews are edited for clarity. Streetwise Reports does not make editorial comments or change experts' statements without their consent.
  4) The interview does not constitute investment advice. Each reader is encouraged to consult with his or her individual financial professional and any action a reader takes as a result of information presented here is his or her own responsibility. By opening this page, each reader accepts and agrees to Streetwise Reports' terms of use and full legal disclaimer.
  5) From time to time, Streetwise Reports LLC and its directors, officers, employees or members of their families, as well as persons interviewed for articles and interviews on the site, may have a long or short position in securities mentioned and may make purchases and/or sales of those securities in the open market or otherwise.

Top 5 Life Sciences Stocks To Buy Right Now: Sibling Group Holdings Inc (SIBE)

Sibling Group Holdings Inc., incorporated on December 28, 1988, is a development-stage company. During the year ended December 31, 2012, the Company was not engaged in any business operations.

The Company has entered into an Agreement of Acquisition and Plan of Reorganization with Sibling Entertainment Group, Inc. (Sibling) to acquire Sibling�� four wholly owned subsidiaries: Sibling Theatricals, Inc., Sibling Pictures, Inc., Sibling Music Corp., and Sibling Properties, Inc. and their subsidiaries, including Dick Foster Productions, Inc., Adrenaline MMA, Inc., Hats Holdings, Inc. amongst others. The Company was organized primarily for the purpose of importing fruits and vegetables from Latin America.

Advisors' Opinion:

• [By Peter Graham]

  Small cap holding companies Sibling Group Holdings Inc (OTCMKTS: SIBE), Tranzbyte Corp (OTCMKTS: ERBB) and Readen Holding Corp (OTCMKTS: RHCO) are in the business of holding or acquiring other companies. They have also been getting some attention lately in various investment newsletters and not necessarily because of acquisitions or other news but rather because of a few recent paid promotions. With that in mind, here is a quick look and a reality check about all three:

  Sibling Group Holdings Inc (OTCMKTS: SIBE) Has Been Quiet Lately

  Small cap Sibling Group Holdings intends to acquire, on a global basis, advanced technology and education management operations in order to enhance and accelerate the delivery of 21st century learning. On Friday, Sibling Group Holdings closed at $0.05 for a market cap of $39,342 plus SIBE is down 96.7% over the past year and down 80% over the past five years according to Google Finance.

Top 5 Life Sciences Stocks To Buy Right Now: Ziggo NV (ZIGGO)

Ziggo NV is the Netherlands-based provider of entertainment, information and communication through television, Internet and telephony services. The Company provides digital, interactive and high definition (HD) television, broadband Internet, data communication and telephony services to both private and corporate customers. To business customers, it offers services over the network. For home use and small business, they are provided through business bundles and packages, such as Office Basis, Internet Plus and All-in-1. Ziggo NV serves around 3 million households, with almost 1.8 million Internet subscribers, more than 2.2 million subscribers using digital television and about 1.4 million telephony subscribers. Additionally, it operates a music streaming service, Ziggo Muziek, and a fiber optic network. The Company is wholly owned by Zesko Holding BV and has several subsidiaries, such as Zesko BV, Ziggo Bond Company Holding BV and Ziggo Bond Company BV, among others. Advisors' Opinion:

• [By Sarah Jones]

  Ziggo NV (ZIGGO), a Dutch cable-television operator, advanced 4.5 percent to 29.58 euros, after Vodafone confirmed it approached Kabel Deutschland. Liberty Global Inc., which owns an 18 percent stake in Ziggo, had also considered bidding for the German company, two people familiar with the matter said in April.

Top 5 Life Sciences Stocks To Buy Right Now: Cerus Corporation(CERS)

Cerus Corporation, a biomedical products company, engages in the development and commercialization of the INTERCEPT Blood System. The company?s INTERCEPT system is designed to inactivate blood-borne pathogens in donated blood components intended for transfusion. It markets the INTERCEPT system for platelets and plasma primarily in Europe, the Russian Federation, and the Middle East. The company is also developing INTERCEPT Blood System for red blood cells or red blood cell system, which is designed to inactivate blood-borne pathogens in donated red blood cells for transfusion. Cerus Corporation has collaboration agreements with Baxter International, Inc.; and BioOne Corporation, as well as the United States Armed Forces. The company was founded in 1991 and is based in Concord, California.

Advisors' Opinion:

• [By Seth Jayson]

  Cerus (Nasdaq: CERS  ) is expected to report Q1 earnings on April 30. Here's what Wall Street wants to see:

  The 10-second takeaway
  Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Cerus's revenues will expand 15.0% and EPS will remain in the red.